title: The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients.
authors: Marina
authors: M
authors: Sagud
authors: Matea
authors: M
authors: Nikolac
authors: Alma
authors: A
authors: Mihaljevic-Peles
authors: Gordana
authors: G
authors: Nedic
authors: Bjanka
authors: B
authors: Vuksan Cusa
authors: Maja
authors: M
authors: Mustapic
authors: Miro
authors: M
authors: Jakovljevic
authors: Dorotea
authors: D
authors: Muck-Seler
authors: Nela
authors: N
authors: Pivac
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001792:Blood Platelets / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy*; D012701:Serotonin / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D013844:Thiazoles / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D012702:Serotonin Antagonists; D013844:Thiazoles; D012701:Serotonin; C092292:ziprasidone